Table 4.
Mean values of selected measures at the baseline, end of treatment (EOT), after 2 years follow-up (2yFU) and 5 years of follow-up (2yFU).
| Baseline | EOT | 2yFU | 5yFU | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Mean | SD | Mean | SD | p | Mean | SD | p | Mean | SD | p | |
| albumins, g/dL | 137 | 4.05 | 0.53 | 4.22 | 0.50 | <0.001 | 4.35 | 0.41 | <0.001 | 4.35 | 0.50 | 0.39 |
| bilirubin, g/dL | 141 | 1.47 | 3.76 | 1.40 | 1.57 | 0.11 | 0.91 | 0.54 | <0.001 | 0.93 | 0.50 | 0.13 |
| MELD, score | 121 | 8.66 | 2.67 | 8.54 | 2.59 | 0.74 | 7.75 | 1.90 | <0.001 | 7.86 | 1.87 | 0.45 |
| Child-Pugh, score | 123 | 5.35 | 0.80 | 5.36 | 0.91 | 0.97 | 5.16 | 0.50 | <0.001 | 5.11 | 0.41 | 0.19 |
| INR | 143 | 1.13 | 0.19 | 1.13 | 0.16 | 0.22 | 1.08 | 0.12 | <0.001 | 1.07 | 0.14 | 0.05 |
| BMI | 129 | 25.9 | 3.77 | 25.9 | 3.75 | 0.39 | 26.3 | 3.99 | <0.001 | 26.7 | 4.41 | 0.04 |
| stiffness, kPa | 78 | 17.9 | 13.0 | 15.4 | 11.4 | <0.001 | 11.2 | 8.24 | <0.001 | 9.65 | 5.59 | 0.001 |
p values refer to the comparison of the current and preceding time point (Wilcoxon matched paired test); MELD—Model for End-Stage Liver Disease, INR—International Normalized Ratio.